Homeritz Q4FY26 profit before tax drops 42% quarter on quarter to RM 5.6 million
Bitget2026/10/23 09:13- Homeritz’s Q4FY26 profit attributable to owners fell year-over-year to RM 5.01 million.
- Quarterly revenue dropped 12% year-over-year to RM 45.17 million due to lower sales volume.
- FY26 profit attributable to owners declined 10% year-over-year to RM 24.75 million; revenue fell 8% to RM 207.23 million.
- Full-year net cash from operating activities rose 87% year-over-year to RM 44.23 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Terranor Group schedules Q3 results presentation
WTI crude oil futures prices fall by more than 1%
Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment
According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.
GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions
Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.
Crypto prices
More
